LifeMD, Inc. to Post Q2 2022 Earnings of ($0.23) Per Share, B. Riley Forecasts (NASDAQ:LFMD)

LifeMD, Inc. (NASDAQ:LFMDGet Rating) – Stock analysts at B. Riley cut their Q2 2022 earnings estimates for shares of LifeMD in a report released on Monday, May 16th. B. Riley analyst M. Wiesenberger now forecasts that the company will post earnings of ($0.23) per share for the quarter, down from their previous forecast of ($0.20). B. Riley also issued estimates for LifeMD’s Q3 2022 earnings at ($0.15) EPS, Q4 2022 earnings at ($0.05) EPS, FY2022 earnings at ($0.68) EPS and FY2023 earnings at ($0.13) EPS.

LifeMD (NASDAQ:LFMDGet Rating) last issued its quarterly earnings results on Monday, March 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.39) by $0.10. The business had revenue of $27.42 million for the quarter, compared to the consensus estimate of $27.45 million. LifeMD had a negative return on equity of 2,115.32% and a negative net margin of 60.35%.

Several other equities research analysts have also recently weighed in on the stock. Colliers Securities reaffirmed a “buy” rating on shares of LifeMD in a research report on Tuesday, March 22nd. BTIG Research decreased their price objective on shares of LifeMD to $8.00 and set a “na” rating on the stock in a research note on Monday. Finally, Zacks Investment Research upgraded LifeMD from a “sell” rating to a “hold” rating in a research note on Wednesday, March 9th.

LFMD opened at $2.13 on Thursday. LifeMD has a 52-week low of $1.85 and a 52-week high of $16.28. The business’s fifty day moving average is $2.97 and its 200-day moving average is $3.64.

Hedge funds and other institutional investors have recently bought and sold shares of the business. B. Riley Financial Inc. increased its holdings in shares of LifeMD by 5.2% during the first quarter. B. Riley Financial Inc. now owns 1,200,759 shares of the company’s stock worth $4,239,000 after buying an additional 59,658 shares in the last quarter. Two Sigma Advisers LP increased its holdings in LifeMD by 10.8% in the 3rd quarter. Two Sigma Advisers LP now owns 512,700 shares of the company’s stock worth $3,184,000 after purchasing an additional 50,100 shares in the last quarter. Two Sigma Investments LP increased its holdings in LifeMD by 4.2% in the 3rd quarter. Two Sigma Investments LP now owns 473,077 shares of the company’s stock worth $2,938,000 after purchasing an additional 19,120 shares in the last quarter. BlackRock Inc. raised its position in LifeMD by 0.9% in the fourth quarter. BlackRock Inc. now owns 423,485 shares of the company’s stock valued at $1,640,000 after purchasing an additional 3,603 shares during the last quarter. Finally, Granahan Investment Management LLC boosted its stake in shares of LifeMD by 448.1% during the first quarter. Granahan Investment Management LLC now owns 295,747 shares of the company’s stock valued at $1,044,000 after purchasing an additional 241,793 shares in the last quarter. 19.36% of the stock is currently owned by hedge funds and other institutional investors.

About LifeMD (Get Rating)

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers.

Read More

Earnings History and Estimates for LifeMD (NASDAQ:LFMD)

Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.